Radikale Prostatektomie oder „Watchful Waiting“ beim frühen Prostatakarzinom?

Wilt TJ et al (2017) Follow-up of prostatectomy versus observation for early prostate cancer. N Engl J Med 377:132–142 Wilson JRM, Clarke MG, Ewings P, Graham JD, MacDonagh R (2005) The assessment of patient life-expectancy: how accurate are urologists and oncologists? BJU Int 95:794–798 Daskivich TJ et al (2014) Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancer. Cancer 120:3642–3650 Mason MD et al (2015) Final report of the intergroup randomized study of combined androgen-deprivation therapy plus radiotherapy versus androgen-deprivation therapy alone in locally advanced prostate cancer. J Clin Oncol 33:2143–2150 Widmark A et al (2009) Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 373:301–308 Godtman RA et al (2016) Long-term results of active surveillance in the Göteborg randomized, population-based prostate cancer screening trial. Eur Urol 70:760–766 Elkjær MC, Andersen MH, Høyer S, Pedersen BG, Borre M (2018) Multi-parametric magnetic resonance imaging monitoring patients in active surveillance for prostate cancer: a prospective cohort study. Scand J Urol 52:8–13 Hamdy FC et al (2016) 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med 375:NEJMoa1606220